ArticleJAMA network open2026
Trends in Unprotected Left Main Percutaneous Coronary Intervention and Clinical Outcomes.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Unprotected left main percutaneous coronary intervention (LM PCI) is recognized as a reasonable strategy for patients who have coronary artery disease with low anatomic complexity. However, recent trends in its procedural volume, patient characteristics, and procedural techniques and their association with clinical outcomes have not been well described, making it important to confirm the safety of LM PCI in contemporary clinical practice. Objectives: To examine temporal trends in the use and in-hospital outcomes of unprotected LM PCI in Japan. Design, Setting, and Participants: This retrospective cohort study used prospectively collected data from the nationwide, multicenter Japanese Percutaneous Coronary Intervention registry including approximately 1100 PCI-capable institutions across Japan. Data were restricted to the period after the registry's 2019 update to ensure consistency in definitions. Temporal trends in PCI procedures were analyzed from January 2019 through December 2023. Patients with prior coronary artery bypass grafting, recent cardiogenic shock, cardiac arrest within 24 hours of treatment, restenosis, or balloon angioplasty alone were excluded. Exposures: Calendar year of PCI (2019-2023). Main Outcomes and Measures: The primary outcome was in-hospital mortality. Multivariable logistic regression was used to assess temporal trends and whether differences were explained by baseline or procedural characteristics. Results: Among 851 468 included procedures (mean [SD] patient age, 74.1 [10.2] years; 78.1% men), unprotected LM PCI accounted for 9490 of 182 739 PCI procedures in 2019 (5.2%) and 8583 of 164 332 in 2023 (5.2%). From 2019 to 2023, mean (SD) patient age increased from 73.4 (10.1) to 74.6 (10.1) years, and patients were more likely to have heart failure (increasing from 1676 of 9058 cases in 2019 [18.5%] to 1704 of 8200 [20.8%] in 2023). Unadjusted in-hospital mortality increased from 148 cases in 2019 (1.6%) to 157 in 2023 (1.9%), but this was not significant after adjusting for patient characteristics (adjusted odds ratio for 2023 vs 2019: 1.08; 95% CI, 0.85-1.37). From 2019 to 2023, further adjustment for procedural factors, including increased use of radial access (from 5789 cases [63.9%] to 5985 cases [73.0%]) and mechanical circulatory support (from 828 cases [9.1%] to 941 cases [11.5%]), did not alter the association between year and mortality. Conclusions and Relevance: In a nationwide Japanese PCI registry, unprotected LM PCI consistently accounted for 5% of PCI procedures. Although unadjusted in-hospital mortality rose modestly over time, the findings indicate this was largely explained by increasing patient complexity, with risk-adjusted outcomes remaining stable, supporting the continued role of LM PCI as a safe revascularization option in contemporary practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.